Drug Type RNA aptamer |
Synonyms- |
Action modulators, stimulants |
Mechanism Sickle haemoglobin modulators, TfR1 stimulants(Transferrin receptor protein 1 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Preclinical | United States | 09 Dec 2024 |